Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
56.5M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
55.1M
-
Shares change
-
+21.6M
-
Total reported value, excl. options
-
$775M
-
Value change
-
+$330M
-
Put/Call ratio
-
0.13
-
Number of buys
-
64
-
Number of sells
-
-29
-
Price
-
$14.08
Significant Holders of Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) as of Q1 2024
120 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Astria Therapeutics, Inc. - Common Stock, par value $0.001 per share (ATXS) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.1M shares
of 56.5M outstanding shares and own 97.55% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.49M shares), TCG Crossover Management, LLC (5.28M shares), RA CAPITAL MANAGEMENT, L.P. (4.41M shares), FMR LLC (4.32M shares), VR Adviser, LLC (3.61M shares), BlackRock Inc. (3.59M shares), Fairmount Funds Management LLC (3.55M shares), VANGUARD GROUP INC (2.54M shares), STATE STREET CORP (2.22M shares), and Driehaus Capital Management LLC (1.76M shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.